Cancer cells contain building blocks for recurring prostrate cancerNovember 14th, 2007 - 2:07 am ICT by admin
In the study, tests were conducted on tumours removed and preserved from deceased prostate cancer patients during “rapid autopsies” immediately after death.
During the course of treatment all the patients had received androgen-blocking therapies to suppress tumour growth.
The analysis made the team detect the key proteins in the tumours, or enzymes, needed for a cell to produce its own testosterone from cholesterol present in the cell.
“This study, along with other research in the field, suggests that cancer cells may have the ability to adapt and produce their own androgens that permit these cancer cells to survive,” said Nelson.
“While this study does not prove that the cancer cells act in this way, it does show it is possible,” he added.
In order to deprive cancer cells of the hormones that fuel their growth androgen-deprivation therapy is routinely used in the treatment of advanced (metastatic) prostate cancer.
However, cancer cells become ‘androgen independent’ over time and grow even in the presence of the medications.
New medications are being clinically tested with the goals of blocking androgen synthesis.
Abiraterone, for example, inhibits the enzymes in the metabolic pathways, which convert cholesterol to androgens, and work by blocking androgen synthesis in adrenal gland and possibly in the tumours themselves. (ANI)
- Heres how prostate cancer develops resistance to androgen-deprivation therapy - Jun 02, 2008
- Discovery shows statins could fight cancer - Sep 14, 2012
- Prostate cancer treatment 'ups risk of colorectal cancer' - Nov 16, 2010
- Slowing down prostate cancer by starving its cells - Nov 03, 2011
- Gene fusion is the 'smoking gun' in the development of prostate cancer: Study - May 19, 2010
- Biophysicist attempts to block protein to prevent breast, prostate cancer - Apr 20, 2011
- Bad cholesterol feeds brain tumours - Sep 16, 2011
- Why PSA levels reflect prostate cancer progression - Jan 14, 2011
- Hormone therapy 'doubles survival chances in men with prostate cancer' - Mar 25, 2011
- High level of testosterone may speed up prostate cancer - Jul 31, 2012
- Pomegranate juice could be key to new cancer therapies - Dec 13, 2010
- Antioxidant protein promotes clogging of arteries, says study - Jan 11, 2011
- Now, prostate cancer can be inhibited without disturbing body processes - Aug 10, 2010
- Protein that protects against prostate cancer discovered - Feb 01, 2011
- Circulating tumour cells tied to poorer survival in pancreatic cancer sufferers - May 29, 2010
Tags: adrenal gland, androgen, androgens, autopsies, cancer cells, cancer research center, cells act, cholesterol, elahe, enzymes, fred hutchinson cancer, medications, metabolic pathways, metastatic prostate cancer, peter nelson, prostate cancer patients, prostrate cancer, proteins, synthesis, tumour growth